Hadean Ventures — Full Portfolio
23 tracked investments · listed companies and verified rows first
Contineum is a biopharmaceutical company developing small molecule drug candidates to treat inflammatory and fibrotic diseases by modulating critical disease pathways.
BiotechHealthtech
Carmine Stengone(President and Chief Executive Officer)in
Co-investorsRed Tree VentureSamsara BioCapitalCasdin CapitalFranklin TempletonSectoral Asset Management
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs.
AI & Machine LearningBiotechMedical Devices
Beatriz Llamusí(Chief Scientific Officer & Co-Founder)in
Co-investorsBpifranceColumbus Venture PartnersSound BioventuresAdBio partnersInvivo Capital Partners
Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis.
BiotechDigital HealthFemTechMedical DevicesStockholm, SE
Patric Stenberg(Founder)Gunilla Ekström(Founder)in
Co-investorsAmboy Street VenturesForeground CapitalHealthCapIndustrifondenXGEN VentureCatalyze Capital
SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways.
BiotechDeep TechHealthtechMartinsried, DE
Dr. Jens Ruhe(Co-founder, Managing Director & Chief Operating Officer)Dr. Matthias Schneider(Co-founder & Chief Scientific Officer)Dr. Jan Poth(Managing Director, Chief Executive Officer)Dr. Jürgen Reeß(Chief Medical Officer)
Co-investorsAndera PartnersKurma PartnersBayern Kapital
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR
Alain Fischer(Founding Scientist)
Co-investorsKurma PartnersBpifrancePontifax Venture CapitalSunstone CapitalV-Bio Ventures
Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Darshan Dalal(Chief Medical Officer)in
Co-investorsM VenturesSofinnova Partners4BIO CapitalBioqube Ventures
Alex Therapeutics builds clinically validated digital therapeutics and therapy companion apps that combine CBT-based interventions, consumer product design, and AI/ML to support patients managing complex conditions such as rare diseases and cancer.
AI & Machine LearningDigital HealthHealthtechMedical Devices
John Drakenberg(Co-founder)inOliver Fleetwood(Co-founder)in
Co-investorsInnovestor VenturesScale Capital
Digital therapeutics company based in Stockholm developing AI-powered mental health treatments.
Clinical-stage biotech developing medicines through modulation of microRNAs; lead compound is ATX-01.
Co-investorsAdBio partnersSound Bioventures
Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients.
BiotechDigital HealthHealthtechMedical DevicesStockholm, SE
Lars E. Gustafsson(Co-founder (deceased))
BoardMagnus Persson(Chairman of the Board)
Co-investorsEIR Ventures
CardioMech develops a transcatheter mitral valve repair system (MVRS) that delivers artificial chords via a transfemoral, transseptal catheter approach to treat degenerative mitral regurgitation on a beating heart.
BiotechHealthtechMedical DevicesTrondheim, NO
Richard Nehm(Executive Officer, Director)Jan Habrekke(Director)Vic, Jr. Bertrand(Director)Jacob Bergsland(Executive Officer, Director)Nikolai Hiorth(Executive Officer)Mark Novotny(Director)
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsCambridge Innovation CapitalSeroba Life SciencesBGVBioGeneration VenturesForbionGimv+1 more
European biopharmaceutical company advancing a nectin-4 antibody-drug conjugate for solid tumour oncology.
Co-investorsPontifax Venture CapitalRA Capital
Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.
BiotechMedical Devices
Jennifer Jarrett(Chief Executive Officer & Board Director)inSherwin Sattarzadeh(Chief Operating Officer)inBecker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)inJim Baker(Chief Corporate Affairs Officer)inBrian Burkavage(Senior Vice President, Finance)in
Co-investorsEIR VenturesM VenturesSEED Capital DenmarkSunstone CapitalYsios CapitalMaverick Ventures+1 more
NEL develops software-driven solutions for motion analysis and diagnostics to support epilepsy patients and their physicians.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsCatalyze Capital
Nisonic develops FAST-ICP software that uses transorbital ultrasound imaging and machine learning to non-invasively detect raised intracranial pressure by measuring optic nerve sheath properties.
AI & Machine LearningHealthtechMedical DevicesTrondheim, NO
Co-investorsSarsia Management ASInvestinor
Oncoinvent is a biotechnology company focused on drug development and commercialization in the pharmaceutical sector.
BiotechHealthtechMedical DevicesOslo, NO
Oystein Soug(CEO)inAnders Månsson(Business Executive)in
Co-investorsFarvatn Venture
Ribbon Bio develops cell-free DNA synthesis and analysis products for research and diagnostics applications.
BiotechDeep Tech
Dr. Wladimir Labeikovsky(Co-Founder, Head of Data Operations)
Co-investorsxista science venturesLansdowne Partners
SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Roopom Banerjee(Executive Chairman)in
Co-investorsFSGLU InnovationSciety
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.
BiotechMedical DevicesUtrecht, NL
Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in
Co-investorsAndera PartnersCurie CapitalFund+RotripBioGeneration VenturesInkef+1 more
Vaccine development company based in Vienna.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.